These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 19373946

  • 1. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
    Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A.
    J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
    [Abstract] [Full Text] [Related]

  • 2. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.
    Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I.
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):502-8. PubMed ID: 15037262
    [Abstract] [Full Text] [Related]

  • 3. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB.
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [Abstract] [Full Text] [Related]

  • 4. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A.
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [Abstract] [Full Text] [Related]

  • 5. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ, Han F, Gao SL, A DL, Pang ZL.
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [Abstract] [Full Text] [Related]

  • 6. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T, Sawabata N, Funaki S, Inoue M, Kadota Y, Shintani Y, Okumura M.
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [Abstract] [Full Text] [Related]

  • 7. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC, Zheng Z, Li J, Chen T, Liu LG, Wei X.
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [Abstract] [Full Text] [Related]

  • 8. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C.
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A, Shirakusa T, Miyoshi T, Hamada T, Enatsu S, Maekawa S, Hiratsuka M.
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [Abstract] [Full Text] [Related]

  • 11. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP.
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [Abstract] [Full Text] [Related]

  • 12. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, Hölscher AH.
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
    Su XD, Wang X, Rong TH, Long H, Fu JH, Lin P, Zhang LJ, Wang SY, Wen ZS, Ma GW.
    Zhonghua Wai Ke Za Zhi; 2007 Nov 15; 45(22):1543-5. PubMed ID: 18282391
    [Abstract] [Full Text] [Related]

  • 14. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC.
    J Thorac Cardiovasc Surg; 2001 Sep 15; 122(3):548-53. PubMed ID: 11547308
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2008 Oct 15; 86(4):1092-7. PubMed ID: 18805138
    [Abstract] [Full Text] [Related]

  • 17. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
    Doddoli C, Aragon A, Barlesi F, Chetaille B, Robitail S, Giudicelli R, Fuentes P, Thomas P.
    Eur J Cardiothorac Surg; 2005 Apr 15; 27(4):680-5. PubMed ID: 15784374
    [Abstract] [Full Text] [Related]

  • 18. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
    Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y.
    Eur J Cardiothorac Surg; 2008 Jul 15; 34(1):187-95. PubMed ID: 18457958
    [Abstract] [Full Text] [Related]

  • 19. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ, Bryant AS.
    Ann Thorac Surg; 2008 Aug 15; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [Abstract] [Full Text] [Related]

  • 20. Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns.
    Wu N, Lv C, Yan S, Duan H, Zheng Q, Wang J, Xiong H, Yang Y.
    Interact Cardiovasc Thorac Surg; 2008 Apr 15; 7(2):240-3. PubMed ID: 18077504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.